Abstract
A Phase II Trial of Azacitidine (AZA) in Combination with Ruxolitinib (RUX) in Myelodysplastic Syndrome/Myeloproliferative Neoplasms (MDS/MPNs)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have